biomedicina slovenica

re="Cancer Res" : 68

  1. Templeton Arnoud; Ocaña Alberto; Šeruga Boštjan; Vera-Badillo Francisco; Carlsson Lindsay; Bedard Philippe L.; Amir Eitan
    Management of small HER2 overexpressing tumours
    2012 ►
  2. Vardy JL; Pond Gregory Russell; Dodd Anna; Warr David; Šeruga Boštjan; Clemons Mark J; Bordeleau Louise; Goodwin Peter C; Tannock Ian
    A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer
    2012 ►
  3. Merlo Domenico Franco; Primic-Žakelj Maja
    Breast cancer incidence trends in European women aged 20-39 years at diagnosis
    2012 ►
  4. Erčulj Nina; Faganel-Kotnik Barbara; Debeljak Maruša; Jazbec Janez; Dolžan Vita
    DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia
    2012 ►
  5. Knez L; Košnik M; Ovčariček T; Sadikov A; Sodja E; Kern I; Čufer T
    Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy
    2012 ►
  6. Perše M; Injac R; Štrukelj B; Cerar A
    High fat mixed lipid diet modifies protective effects of exercise on 1,2 dimethylhydrazine induced colon cancer in rats
    2012 ►
  7. Hu-Lieskovan Siwen; Bračko Matej; Velenik Vaneja
    EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients
    2011 ►
  8. Hmeljak Julija; Erčulj Nina; Dolžan Vita; Kern Izidor; Coer Andrej
    BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients
    2011 ►
  9. Šeruga Boštjan; Amir Eitan
    Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis
    2010 ►
  10. Borštnar Simona; Sadikov Aleksander; Možina Barbara; Čufer Tanja
    High levels of uPA and PAI-1 predict a good response to anthracyclines
    2010 ►
  11. Perhavec Andrež; Pohar-Perme Maja; Hočevar Marko; Bešić Nikola; Žgajnar Janez
    Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node
    2010 ►
  12. Rokavec Matjaž; Schroth Werner; Amaral Sandra M; Fritz Peter; Antoniadou Lydia; Glavač Damjan; Simon Wolfang; Schwab Matthias; Eichelbaum Michel; Brauch Hiltrud
    A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer
    2008 ►
  13. Korde Larissa A; Lusa Lara; McShane Lisa; Lebowitz Peter F; Lukes LuAnne; Camphausen Kevin; Parker Joel S; Swain Sandra M; Hunter Kent; Zujewski Jo Anne
    Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
    2009 ►
  14. Golouh R; Čufer T; Sadikov A; Nussdorfer P; Usher PA; Brunner N; Schmitt M; Lesche R; Maier S; Timmermans M; Foekens JA; Martens JW
    The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study
    2008 ►
  15. Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    2009 ►
  16. Zhang Yi; Sieuwerts Anieta M; McGreevy Michelle; Casey Graham; Čufer Tanja; Paradiso Angelo; Harbeck Nadia; Span Paul N; Hicks David G; Golouh Rastko
    The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
    2009 ►
  17. Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Lindtner J; Čufer T
    Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
    2009 ►
  18. Karina M; Čufer Tanja
    Preliminary safety data of the EORTC 10994/BIG 00-01 neoadjuvant trial comparing 3 cycles of docetaxel followed by 3 cycles of epirubicin-docetaxel versus 6 cycles of FEC 100 in patients with locally advanced/inflammatory or large operable breast cancer
    2006 ►
  19. Golouh Rastko; Čufer Tanja; Sadikov A; Nusdorfer P; Usher P; Bruenner N; Schmitt M; Harbeck N; Lesche R; Meier S
    Stathmin-1 protein expression is associated with disease recurrence in tamoxifen-treated steroid hormone receptor positive early breast cancer: an immunohistochemical study
    2006 ►
  20. de Haas T; Hasselt N; Troost D; Caron H; Popović M; Zadravec-Zaletel L; Grajkowska W; Perek M; Osterheld MC; Ellison D
    Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression
    2008 ►
  21. Ravnihar B; Pompe-Kirn V
    Experiences of the cancer registry in Slovenia
    1975 ►
  22. Debrakeleer S.; De Greve Jacques; Krajc Mateja; Sermijn E.; Fontaine C.; Goelen Guido; Bonduelle M.; Novaković Srdjan; Teugels Erik
    Germline mutation of the BARD1 ankyrin domain in a non-BRCA1/2 breast cancer family
    2006 ►
  23. Rokavec Matjaž; Justenhoven Christina; Schroth Werner; Istrate Monica Adina; Haas Susanne; Fischer Hans-Peter; Vollmert Caren; Illig Thomas; Hamann Ute; Ko Yon-Dschun; Glavač Damjan; Brauch Hiltrud
    A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk
    2007 ►
  24. Mezzanzanica Delia; Fabbi Marina; Bagnoli Marina; Staurengo Samantha; Losa Marco; Balladore Emanuela; Alberti Paola; Lusa Lara; Ditto Antonino; Ferrini Silvano
    Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients
    2008 ►
  25. Žgajnar Janez; Hočevar Marko; Podkrajšek Maja; Hertl Kristijana; Frković-Grazio Snježana; Vidmar Gaj; Bešić Nikola
    Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early patients
    2006 ►
  26. Borštnar S; Vrhovec I; Čufer T
    High levels of uPA and PAI-1 predicts a good response to antracyclines
    2004 ►
  27. Cauley Jane A; Norton Larry; Lippman Marc E; Eckert Stephen; Krueger Kathryn A; Purdie David W; Farrerons Jordi; Karasik Avraham; Mellstrom Dan; Kocijančič Andreja
    Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
    2001 ►
  28. Clayton Richard N; Pfeifer Marija; Atkinson A Brew; Belchetz Paul; Wass John AH; Kyrodimou Effie; Vanderpump Mark; Simpson David; Bicknell John; Farrell William E
    Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins
    2000 ►
  29. Bonnefoi H; Biganzoli L; Čufer T; Mauriac L; Hamilton A; Schaefer P; Picart M
    An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer
    2001 ►
  30. Serša Gregor; Čemažar Maja
    A potential vascular targeted mechanism of electrochemotherapy
    2001 ►
  31. Čemažar Maja; Dachs Gabi U; Wilson Ian; Tozer Gillian M; Serša Gregor
    In vivo gene delivery to solid tumors by electroporation alone or combined with lipofectin-based techniques
    2001 ►
  32. Tozer Gillian M; Prise Vivien E; Wilson John; Čemažar Maja; Shan Siqing; Dewhirst Mark W; Barber Paul R; Vojnović Borivoj; Chaplin David J
    Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability
    2001 ►
  33. Coralli Claudia; Čemažar Maja; Kanthou Chryso; Tozer Gillian M; Dachs Gabi U
    Limitations of the reporter green fluorescent protein under simulated tumor conditions
    2001 ►
  34. Brauch H; Weirich G; Brieger J; Glavač D; Rodl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Mašera A
    VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation
    2000 ►
  35. Tucker ON; Teng LS; Hočevar M; Dannenberg AJ; Fahey TJ
    Bile acids induce cycloxygenase-2 in human pancreatic cancer cell lines
    1999 ►
  36. Serša Gregor; Kržič Mateja; Šentjurc Marjeta; Ivanuša Teodora; Beravs Katarina; Čemažar Maja; Auersperg Marija; Swartz Harold M
    Reduced tumor oxygenation by treatment with vinblastine
    2001 ►
  37. Strojan Primož; Budihna Marjan; Šmid Lojze; Svetic Branka; Vrhovec Ivan; Kos Janko; Škrk Janez
    Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck
    2000 ►
  38. Kos Janko; Krašovec Marta; Cimerman Nina; Nielsen Hans Jorgen; Christense Ib Jarle; Bruenner Nils
    Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis
    2000 ►
  39. Sier Cornelis FM; Casetta Giovanni; Verheijen Jan H; Tizziani Alessandro; Agape Vittorio; Kos Janko; Blasi Francesco; Hanemaaijer Roeland
    Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers
    2000 ►
  40. Kos J; Krašovec M; Schweiger A; Cimerman N; Štabuc B; Nielsen HJ; Christensen IJ; Stephens RW; Brunner N
    Prognostic relevance of serum cathepsins B, H and L and their inhibitors in melanoma and colorectal cancer
    1998 ►
  41. Kolarič K; Potrebica V; Červek J
    Phase-II clinical trial of 4-epi-doxorubicin in metastatic solid tumors
    1983 ►
  42. Plesničar S; Klanjšček G; Modic S; Rustia M
    Growth characteristics of pulmonary metastases from human sarcomas
    1979 ►
  43. Serša G; Štabuc B; Čemažar M; Miklavčič D; Rudolf Z
    Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients
    2000 ►
  44. Pavelić Jasminka; Lamovec Janez; Novak Janez; Gall-Trošelj Koraljka; Kapitanović Sanja; Pavelić Krešimir
    Collision tumour in the pelvic cavity: rectal leiomysarcoma and prostate adenocarcinoma
    2000 ►
  45. Prechtl Anita; Thomssen Christoph; Meisner Christoph; Untch Michael; Weikel Werner; Wieland Gabriele; Lisboa Bjoern W; Hantschmann Peter; Beck Thomas; Čufer Tanja; et al ;
    Risk-adapted adjuvant chemotherapy in node-negative breast cancer patients guided by prognostic factors uPA and PAl-1: first interim-analysis of a randomized trial
    2000 ►
  46. Bervar Aleš; Zajc Irena; Sever Nataša; Levičar Nataša; Filipič Metka; Kos Janko; Lah Tamara
    Expression of cysteine proteinases and their inhibitors levels in relation to invasiveness of human breast tumor cell lines
    2000 ►
  47. Lah Tamara T; Čerček Miha; Blejec Andrej; Kos Janko; Gorodetsky Ella; Somers Robert; Daskal Ierachmiel
    Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators
    2000 ►
  48. Novaković Srdjan; Ihan Alojz; Jezeršek Barbara
    Effectiveness of a simply designed tumor vaccine in prevention of malignant melanoma development
    1999 ►
  49. Levičar N; Blejec A; Kos J; Golouh R; Vrhovec I; Frkovič-Gracio S; Lah TT
    Prognostic impact of serine and cysteine proteinases and their inhibitors in breast carcinoma
    1999 ►
  50. Bonnefoi H; Biganzoli L; Čufer T; Hamilton A; Mauriac L; Van Hoorebeeck I; Piccart M
    A feasibility study of epirubicin (E) in combination with cyclophosphamide (C) and infusional 5-fluorouracil (F-infu)(CEF-infu) as primary treatment of large operable (LO) or locally advanced/inflammatory (LA/I) breast cancer (BC)
    1999 ►
  51. Kos Janko; Nielsen Hans-Jorgen; Krašovec Marta; Christensen Ib Jarle; Cimerman Nina; Stephens Ross W; Bruenner Nils
    Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer
    1998 ►
  52. Strojnik Tadej; Kos Janko; Židanik Boris; Golouh Rastko; Lah Tamara
    Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors
    1999 ►
  53. Foekens JA; Kos J; Peters HA; Krašovec M; Look MP; Cimerman N; Meijer-van Gelder ME; Henzen-Logmans SC; van Putten VLJ; Klijn JGM
    Prognostic significance of cathepsin B and L in primary human breast cancer
    1998 ►
  54. Lah TT; Levičar N; Kos J; Golouh R; Nils B; Werle B; Ebert W
    Altered expression of stefins, the inhibitors of cysteine cathepsins, are associated with bad prognosis of breast and lung carcinoma
    1998 ►
  55. Čemažar Maja; Miklavčič Damijan; Serša Gregor
    Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy
    1998 ►
  56. Kos Janko; Štabuc Borut; Schweiger Ana; Krašovec Marta; Cimerman Nina; Kopitar-Jerala Nataša; Vrhovec Ivan
    Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients
    1997 ►
  57. Serša G; Čemažar M; Miklavčič D
    Potentiation of CDDP antitumor effectiveness by electric pulses
    1997 ►
  58. Ledakis P; Tester WT; Rosenberg N; Romero-Fischmann D; Daskal I; Lah TT
    Cathepsins D, B, and L in malignant human lung tissue
    1996 ►
  59. Lah Tamara T; Calaf Gloria; Kalman Endre; Shinde Balasahib G; Somers Robert; Estrada Sandino; Salero Enrique; Russo Jose; Daskal Ierachmiel
    Cathepsins D, B, and L in transformed breast epithelial cells
    1996 ►
  60. Goldhirsch A; Lindtner J; Novak J; Senčar M; Červek J; Cerar O; Štabuc B; Golouh R; Lamovec J; Jančar J; Šebek S
    Perioperative and conventionally timed chemotherapy in operable breast cancer: the Ludwig breast cancer study V
    1986 ►
  61. Goldhirsch A; Lindtner J; Novak J; Eržen D; Senčar M; Červek J; Cerar O; Štabuc B; Golouh R; Lamovec J; Jančar J; Šebek S
    Randomized perioperative therapy in operable breast cancer: the Ludwig trial V
    1989 ►
  62. Serša G; Čemažar M; Miklavčič D
    Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice
    1995 ►
  63. Hedley David W; Lindtner J; Novak J; Naglas M; Červek J; Vodnik A; Majdič E; Mavec P; Golouh R; Lamovec J; Šebek S; Senčar M; Štabuc B
    Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer
    1987 ►
  64. Korbelik M; Krošl G; Chaplin DJ
    Photofrin uptake by murine macrophages
    1991 ►
  65. Čabrijan T; Levanat S; Pekić B; Pavelić J; Spaventi R; Frahm H; Zjačić-Rotkvić V; Goldoni V; Vrbanec D; Misjak M
    The role of insulin-related substance in Hodgkin's disease
    1991 ►
  66. Kolarić K; Potrebica V; Vukas D; Mechl Z; Sopkova B
    Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study
    1988 ►
  67. Roth A
    Combination of chemotherapy and irradiation: a new approach in the treatment of locally advanced esophageal cancer
    1988 ►
  68. Milas L; Serša G; Willingham V; Hunter N; Woo S
    Adoptive immunotherapy as an adjunctive treatment to thoracic irradiation for pulmonary tumor deposits in mice
    1989 ►

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko